1. Home
  2. QMCO vs INO Comparison

QMCO vs INO Comparison

Compare QMCO & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Corporation

QMCO

Quantum Corporation

HOLD

Current Price

$23.03

Market Cap

129.1M

Sector

Technology

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.28

Market Cap

133.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QMCO
INO
Founded
1980
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.1M
133.4M
IPO Year
2025
1999

Fundamental Metrics

Financial Performance
Metric
QMCO
INO
Price
$23.03
$1.28
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$10.50
$6.75
AVG Volume (30 Days)
1.6M
4.7M
Earning Date
02-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
64.34
54.18
EPS
N/A
N/A
Revenue
$372,827,000.00
$42,220,086.00
Revenue This Year
$0.32
$20,156.19
Revenue Next Year
$8.35
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
6.65
19.37
52 Week Low
$4.19
$0.56
52 Week High
$27.80
$2.72

Technical Indicators

Market Signals
Indicator
QMCO
INO
Relative Strength Index (RSI) 60.20 56.38
Support Level $5.22 $1.22
Resistance Level $27.80 $1.79
Average True Range (ATR) 1.77 0.10
MACD -0.29 0.00
Stochastic Oscillator 65.12 45.00

Price Performance

Historical Comparison
QMCO
INO

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: